State Street Corp cut its holdings in shares of Corteva, Inc. (NYSE:CTVA - Free Report) by 50.9% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 37,539,761 shares of the company's stock after selling 38,982,633 shares during the quarter. State Street Corp owned 5.63% of Corteva worth $2,914,962,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. EFG International AG acquired a new stake in Corteva during the second quarter worth approximately $25,000. Compass Financial Management LLC bought a new position in Corteva during the 2nd quarter worth $25,000. Elevation Wealth Partners LLC raised its holdings in Corteva by 334.6% in the 2nd quarter. Elevation Wealth Partners LLC now owns 339 shares of the company's stock valued at $29,000 after acquiring an additional 261 shares in the last quarter. Clearstead Trust LLC acquired a new position in Corteva in the 2nd quarter valued at $31,000. Finally, N.E.W. Advisory Services LLC acquired a new position in Corteva in the 2nd quarter valued at $33,000. 81.54% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
CTVA has been the topic of several analyst reports. JPMorgan Chase & Co. reduced their target price on Corteva from $19.00 to $16.00 and set an "overweight" rating on the stock in a report on Friday, November 13th. New Street Research set a $17.00 price target on Corteva in a research report on Monday, October 5th. Argus reaffirmed a "buy" rating and issued a $91.00 price target on shares of Corteva in a research note on Friday, September 18th. Oppenheimer cut shares of Corteva from an "outperform" rating to a "market perform" rating in a research report on Friday, November 13th. Finally, Barclays started coverage on shares of Corteva in a research report on Thursday. They set an "equal weight" rating and a $11.00 price objective for the company. Fourteen equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Corteva currently has a consensus rating of "Moderate Buy" and an average price target of $48.83.
Read Our Latest Report on CTVA
Insider Activity at Corteva
In related news, CEO Luther C. Iv Kissam bought 32,292 shares of the company's stock in a transaction dated Friday, November 13th. The stock was purchased at an average price of $9.30 per share, with a total value of $300,315.60. Following the completion of the acquisition, the chief executive officer owned 185,379 shares of the company's stock, valued at $1,724,024.70. The trade was a 21.09% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.15% of the company's stock.
Corteva Price Performance
Shares of CTVA stock opened at $7.89 on Friday. The business has a fifty day simple moving average of $29.54 and a 200 day simple moving average of $67.94. The company has a market cap of $5.27 billion, a P/E ratio of 4.15, a P/E/G ratio of 1.22 and a beta of 0.58. The company has a quick ratio of 1.08, a current ratio of 1.56 and a debt-to-equity ratio of 0.14. Corteva, Inc. has a twelve month low of $7.82 and a twelve month high of $90.97.
Corteva Cuts Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 15th. Shareholders of record on Tuesday, December 1st will be paid a dividend of $0.05 per share. The ex-dividend date of this dividend is Tuesday, December 1st. This is a negative change from Corteva's previous quarterly dividend of $0.18. This represents a $0.20 annualized dividend and a yield of 2.5%. Corteva's payout ratio is presently 37.89%.
Corteva Company Profile
(
Free Report)
Corteva, Inc. is an agricultural science company that develops and supplies products and services for farmers. Its business focuses on seeds and crop protection, including technologies intended to help improve crop performance and manage weeds, insects, and plant diseases. Its seed portfolio includes corn, soybean, and other crop varieties, sold under brands such as Pioneer and Brevant. Corteva's crop protection offerings include herbicides, insecticides, fungicides, and biological products, alongside digital tools and services that support farm decision-making.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Corteva, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Corteva wasn't on the list.
While Corteva currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.